Zalgen Labs LLC
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Website
- zalgenlabs.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $20,615 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Cincinnati Univ Of | 75A50123C00052 | $149,552 | |
| Camris International, LLC | 75N93021F00002 | $54,000 |
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| La Jolla Institute For Immunology | U19AI142790 | $989,912 | |
| La Jolla Institute For Immunology | U19AI142790 | $919,549 |
Similar vendors
About the company
Zalgen Labs LLC is a biotechnology company that specializes in designing and manufacturing biological molecules for federal agencies. Through prime federal contract awards, Zalgen has provided goods including ELISA test kits, antibodies, and diagnostics to the Department of Health and Human Services and the Department of State. These have supported research and testing related to infectious diseases like Lassa fever.
As a subcontractor on federal grants, Zalgen has produced over 40 human monoclonal antibodies at scales from 100mg to multi-gram to enable in vivo efficacy studies, preclinical development, and testing of immunotherapeutics against Lassa fever and other viral hemorrhagic fevers. They have partnered with research institutions like La Jolla Institute for Immunology and Massachusetts General Hospital to supply antibodies, perform characterization assays, and develop stabilized formulations of antibody cocktails. Zalgen has also provided immunodiagnostics to research partners to help characterize immune responses in animal models.
Through both prime contract awards and subcontracts on federal grants, Zalgen Labs has demonstrated specialized capabilities in generating, manufacturing and formulating monoclonal antibodies, ELISA kits, and other biologics to support infectious disease research and countermeasure development. Their partnerships with prominent research institutions also highlight their strengths in preclinical development and testing of novel immunotherapies.
SBA capabilities narrative
Zalgen Labs specializes in the design and production of critical biological molecules for development and commercialization of effective immunotherapeutic platforms; reliable, rapid, and affordable diagnostics targeting neglected human diseases.
Quick answers
Is Zalgen Labs LLC registered in SAM.gov?
Zalgen Labs LLC's SAM.gov registration expired on February 7, 2026.
What is Zalgen Labs LLC's CAGE code?
Zalgen Labs LLC's CAGE code is 6LNY3, and its Unique Entity ID (UEI) is LVBZDR1MSAQ3.
How much has Zalgen Labs LLC received in federal contracts?
Federal contracts obligated $20,615 to Zalgen Labs LLC in fiscal years 2023 through 2027.
What is Zalgen Labs LLC's most recent federal award?
Zalgen Labs LLC's most recent federal contract award is Pan-lassa elisa kits (75N93023P00519), from National Institute of Allergy and Infectious Diseases (NIH), on April 14, 2023.
On GovTribe
See Zalgen Labs LLC's full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors